• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Gene Therapy Partly Restores Cone Receptors In Eyes Of Children Born Color Blind

August 23, 2022 by Deborah Bloomfield

Experimental gene therapy has partly restored the function of the retina’s cone receptors in two children who were born totally colorblind, according to a new study reported in the journal Brain.

Not only have the two patients reported “changes” to their vision, but brain imaging also showed that the researchers were able to reawaken dormant neural circuits and evoke visual signals that had never been experienced by these young people.

The breakthrough comes from two trials testing gene therapies targeting specific genes known to be linked to achromatopsia, a genetic condition also known as total color blindness.

This disease is caused by variants of the genes related to cone cells, one of the two types of photoreceptors within our eye’s retina that are responsible for color vision. Along with not being able to perceive any color, people with achromatopsia also experience generally poor vision and find bright light uncomfortable. 

While previously gene therapies for color blindness have shown hope, there has been some uncertainty about whether dormant cone-signaling pathways in the brain and visual system of people with achromatopsia can be reawakened after years of deprivation.

Advertisement

The answer is yes, according to this new study – providing huge hope for this potentially life-changing gene therapy. 

“Our study is the first to directly confirm widespread speculation that gene therapy offered to children and adolescents can successfully activate the dormant cone photoreceptor pathways and evoke visual signals never previously experienced by these patients,” Dr Tessa Dekker, lead study author from UCL Institute of Ophthalmology, said in a statement sent to IFLScience.

In the new study, UCL researchers used fMRI brain scans to study four children who had received the gene therapy, then compared them to nine untreated patients and 28 volunteers with normal vision.

Advertisement

In two of the four treated children, the imaging showed strong evidence for cone-mediated signals in the brain’s visual cortex coming from the treated eye. Prior to the treatment, there was no evidence of cone function, but now the pair showed neural activity that closely resembled those of the normal-sighted people. 

The team says this feat may only be possible in young people due to the plasticity of their brain and its remarkable ability to adapt. 

“We are demonstrating the potential of leveraging the plasticity of our brains, which may be particularly able to adapt to treatment effects when people are young,” added Dr Dekker. 

Advertisement

The question now is: has the therapy actually gifted the children with color vision? The researchers asked the two patients to complete a psychophysical test of cone function, which showed notable changes in the way the children perceived different levels of contrast. 

One of the patients commented: “Seeing changes to my vision has been very exciting, so I’m keen to see if there are any more changes and where this treatment as a whole might lead in the future.”

The researchers are keen to back up their findings with further research, but it’s currently looking pretty promising. 

Advertisement

“We are still analyzing the results from our two clinical trials, to see whether this gene therapy can effectively improve everyday vision for people with achromatopsia,” said Dr Michel Michaelides, co-lead author from the UCL Institute of Ophthalmology and Moorfields Eye Hospital.

“We hope that with positive results, and with further clinical trials, we could greatly improve the sight of people with inherited retinal diseases.” 

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Apple’s new MagSafe wallet can be located with the ‘Find My’ app if it goes missing
  2. Report: NBA won’t mandate vaccine for players
  3. Soccer-Real, Barca influence on Spain fades along with club superpower status
  4. Appsmith raises $8M to take on the internal corporate app market with open source code

Source Link: Gene Therapy Partly Restores Cone Receptors In Eyes Of Children Born Color Blind

Filed Under: News

Primary Sidebar

  • Unethical Experiments: When Scientists Really Should Have Stopped What They Were Doing Immediately
  • The First Humans Were Hunted By Leopards And Weren’t The Apex Predators We Thought They Were
  • Earth’s Passage Through The Galaxy Might Be Written In Its Rocks
  • What Is An Einstein Cross – And Why Is The Latest One Such A Unique Find?
  • If We Found Life On Mars, What Would That Mean For The Fermi Paradox And The Great Filter?
  • The Longest Living Mammals Are Giants That Live Up To 200 Years In The Icy Arctic
  • Entirely New Virus Detected In Bat Urine, And It’s Only The 4th Of Its Kind Ever Isolated
  • The First Ever Full Asteroid History: From Its Doomed Discovery To Collecting Its Meteorites
  • World’s Oldest Pachycephalosaur Fossil Pushes Back These Dinosaurs’ Emergence By 15 Million Years
  • The Hole In The Ozone Layer Is Healing And On Track For Full Recovery In The 21st Century, Thanks To Science
  • First Sweet Potato Genome Reveals They’re Hybrids With A Puzzling Past And 6 Sets Of Chromosomes
  • Why Is The Top Of Canada So Sparsely Populated? Meet The “Canadian Shield”
  • Humans Are In The Middle Of “A Great Evolutionary Transition”, New Paper Claims
  • Why Do Some Toilets Have Two Flush Buttons?
  • 130-Year-Old Butter Additive Discovered In Danish Basement Contains Bacteria From The 1890s
  • Prehistoric Humans Made Necklaces From Marine Mollusk Fossils 20,000 Years Ago
  • Zond 5: In 1968 Two Soviet Steppe Tortoises Beat Humans To Orbiting Around The Moon
  • Why Cats Adapted This Defense Mechanism From Snakes
  • Mother Orca Seen Carrying Dead Calf Once Again On Washington Coast
  • A Busy Spider Season Is Brewing: Why This Fall Could See A Boom Of Arachnid Activity
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version